Skye Bioscience, Inc. (SKYE) › Shares OutstandingSkye Bioscience, Inc. (SKYE) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2012: 2.53M2013: 7.77M2014: 16.00M2015: 19.90M2016: 21.56M2017: 33.62M2018: 133.91M2019: 182.90M2020: 288.07M2021: 476.11M2022: 3.65M2023: 12.35M2024: 30.97M2025: 33.38M33.38M2012Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202533.38M+7.8%202430.97M+150.8%202312.35M+238.0%20223.65M-99.2%2021476.11M+65.3%2020288.07M+57.5%2019182.90M+36.6%2018133.91M+298.3%201733.62M+55.9%201621.56M+8.3%201519.90M+24.4%201416.00M+105.9%20137.77M+207.4%20122.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share